Recent BLUE News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/26/2024 08:09:08 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/26/2024 08:01:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 11:03:12 AM
- bluebird bio Initiates Restructuring Intended to Optimize Cost Structure and Enable Quarterly Cash Flow Break-Even in the Second Half of 2025 • Business Wire • 09/24/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:02:05 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/16/2024 08:04:42 PM
- bluebird bio Announces Completion of its Restatement and filing of its 2023 Form 10-K and Q1 2024 Form 10-Q • Business Wire • 09/13/2024 08:41:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/13/2024 08:37:13 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/13/2024 08:28:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:04:54 PM
- bluebird bio Announces September Investor Events • Business Wire • 08/28/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 08:06:48 PM
- bluebird bio Announces Receipt of Expected Notices from Nasdaq • Business Wire • 08/23/2024 08:05:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 11:13:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 11:03:21 AM
- bluebird bio Reports Second Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance • Business Wire • 08/14/2024 11:00:00 AM
- bluebird bio Announces Second Quarter 2024 Results Call Date • Business Wire • 08/12/2024 12:00:00 PM
- bluebird bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/02/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 11:38:42 AM
- bluebird bio Reports Inducement Grant to CFO James Sterling Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 07/03/2024 08:05:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:22:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 11:06:00 AM
- bluebird bio Appoints O. James Sterling as Chief Financial Officer • Business Wire • 05/29/2024 11:00:00 AM
- Investors in bluebird bio, Inc. Should Contact The Gross Law Firm Before May 28, 2024 to Discuss Your Rights - BLUE • PR Newswire (US) • 05/21/2024 09:45:00 AM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM